基于网络药理学分析玉液汤治疗糖尿病视网膜病变的机制
Analysis of the Mechanism of Yuye Decoction in the Treatment of Diabetic Retinopathy Based on Network Pharmacology
DOI: 10.12677/pi.2026.153018, PDF,   
作者: 刘怡君*, 李海飞:贵州中医药大学药学院,贵州 贵阳;罗 波:贵州理工学院食品药品制造工程学院,贵州 贵阳;罗志军:贵阳倍隆生物科技有限公司,贵州 贵阳;张勇民#:索邦大学巴黎分子化学研究所,法国 巴黎
关键词: 网络药理学玉液汤糖尿病视网膜病变Network Pharmacology Yuye Decoction Diabetes Retinopathy
摘要: 目的:分析玉液汤治疗糖尿病视网膜病变的主要活性成分、关键靶点和信号通路。方法:使用TCMSP数据库筛选玉液汤的主要活性成分和每个成分对应的靶点,无对应靶点的成分在SwissTargetPrediction数据库预测,将两个数据库的靶点进行整合。在GeneCards、DisGeNet数据库中收集糖尿病视网膜病变的靶点,通过Venny 2.1获得交集靶点。使用Cytoscape 3.9.1软件构建“药物–成分–靶点”的网络。运用STRING作蛋白互作分析,Cytoscape插件MCODE筛选关键靶点。在DAVID数据库中对关键靶点进行GO功能分析,使用R语言包对关键靶点进行KEGG信号通路分析。结果:共筛选出62个玉液汤的主要活性成分,260个交集靶点,13个关键靶点,192条信号通路。白桦脂酸、熊竹素、常春藤皂苷等是主要的活性成分,JAK1、EGFR、IGF1R、ERBB2等是治疗疾病的关键靶点。涉及糖尿病并发症的AGE/RAGE、PI3K/Akt、ErbB、JAK/STAT、VEGF、TNF、凋亡等信号通路的调控。结论:玉液汤可能通过多个生物过程以及介导多个信号通路调节细胞凋亡、细胞增殖、炎症反应、血管生成、免疫等过程进而治疗糖尿病视网膜病变。
Abstract: Objective: To analyze the main active components, key targets, and signaling pathways of Yuye Decoction in the treatment of diabetic retinopathy. Method: The TCMSP database was used to screen the main active components of Yuye Decoction and the corresponding targets of each component. The components without corresponding targets were predicted in the SwissTargetPrediction database, and the targets of the two databases were integrated. The targets of diabetic retinopathy were collected in the GeneCards and DisGeNet databases, and the intersection targets were obtained by Venny 2.1. The “drug-component-target” network was constructed using Cytoscape 3.9.1 software. STRING was used for protein interaction analysis, and the Cytoscape plug-in MCODE was used to screen key targets. GO function analysis of key targets was performed in the DAVID database, and KEGG signaling pathway analysis of key targets was performed using the R language package. Result: A total of 62 main active components of Yuye Decoction, 260 intersection targets, 13 key targets, and 192 signaling pathways were screened out. Mairin, Jaranol, and hederagenin are the main active components, and JAK1, EGFR, IGF1R, and ERBB2 are the key targets for the treatment of diseases. Regulation of AGE/RAGE, PI3K/Akt, ErbB, JAK/STAT, VEGF, TNF, apoptosis, and other signaling pathways involved in diabetic complications. Conclusion: Yuye decoction may regulate cell apoptosis, cell proliferation, inflammatory response, angiogenesis, immunity, and other processes through multiple biological processes and mediate multiple signaling pathways to treat diabetic retinopathy.
文章引用:刘怡君, 罗波, 李海飞, 罗志军, 张勇民. 基于网络药理学分析玉液汤治疗糖尿病视网膜病变的机制[J]. 药物资讯, 2026, 15(3): 155-163. https://doi.org/10.12677/pi.2026.153018

参考文献

[1] Ansari, P., Tabasumma, N., Snigdha, N.N., Siam, N.H., Panduru, R.V.N.R.S., Azam, S., et al. (2022) Diabetic Retinopathy: An Overview on Mechanisms, Pathophysiology and Pharmacotherapy. Diabetology, 3, 159-175. [Google Scholar] [CrossRef
[2] Lin, K., Hsih, W., Lin, Y., Wen, C. and Chang, T. (2021) Update in the Epidemiology, Risk Factors, Screening, and Treatment of Diabetic Retinopathy. Journal of Diabetes Investigation, 12, 1322-1325. [Google Scholar] [CrossRef] [PubMed]
[3] Mounirou, B.A.M., Adam, N.D., Yakoura, A.K.H., Aminou, M.S.M., Liu, Y.T. and Tan, L.Y. (2022) Diabetic Retinopathy. Indian Journal of Endocrinology and Metabolism, 26, 111-118. [Google Scholar] [CrossRef] [PubMed]
[4] 田久卓, 李长辉. 中药干预糖尿病视网膜病变氧化应激机制的研究进展[J]. 中医临床研究, 2024, 16(11): 47-53.
[5] 胡锦浩, 石岩. 玉液汤药物降糖成分与方剂降糖机制研究进展[J]. 辽宁中医药大学学报, 2024, 26(4): 116-123.
[6] 周樱, 祖冬梅, 王丕进, 等. 玉液汤对糖尿病性黄斑水肿的疗效观察及机制探讨[J]. 世界中医药, 2016, 11(11): 2267-2270.
[7] 王璐, 张文风. 张锡纯论治消渴的学术思想探微[J]. 长春中医药大学学报, 2020, 36(3): 412-414.
[8] 何路, 陈贞, 李家璋, 等. 玉液汤合温阳活血利水方治疗糖尿病性黄斑水肿的临床疗效及对血清可溶性E选择素、血管内皮生长因子水平的影响[J]. 河北中医, 2018, 40(8): 1151-1155.
[9] 胡雯婷. 基于内质网应激中的GRP78表达探讨玉液汤对糖尿病大鼠视网膜病变防治作用的实验研究[D]: [硕士学位论文]. 武汉: 湖北中医药大学, 2020.
[10] Wang, H., Su, X., Zhang, Y., et al. (2023) Isoramin Attenuates Retinal Cell Apoptosis in Diabetes Retinopathy Rats. Basic & Clinical Medicine, 43, 265-270.
[11] Khazeei Tabari, M.A., Mirjalili, R., Khoshhal, H., Shokouh, E., Khandan, M., Hasheminasabgorji, E., et al. (2022) Nature against Diabetic Retinopathy: A Review on Antiangiogenic, Antioxidant, and Anti-Inflammatory Phytochemicals. Evidence-Based Complementary and Alternative Medicine, 2022, 159-175. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, J., Zhang, J. and Zhao, Y. (2023) Calycosin Alleviates Oxidative Stress and Pyroptosis Induced by High Glucose in Human Retinal Capillary Endothelial Cells Induced by High Glucose. Current Topics in Nutraceutical Research, 21, 40-46. [Google Scholar] [CrossRef
[13] Zhao, L., Sun, J., Shi, S., Qin, X., Zhang, K. and Xu, J. (2020) Kaempferol Protects Retinal Ganglion Ceils from High-Glucose-Induced Injury by Regulating Vasohibin-1. Neuroscience Letters, 716, Article 134633. [Google Scholar] [CrossRef] [PubMed]
[14] Li, R., Yao, G., Yan, H. and Wang, L. (2021) Effects of Quercetin on Diabetic Retinopathy and Its Association with NLRP3 Inflammasome and Autophagy. International Journal of Ophthalmology, 14, 42-49. [Google Scholar] [CrossRef] [PubMed]
[15] Sun, J. and Zhao, Y. (2022) Stigmasterol Inhibits High Glucose Induced Proliferation and Angiogenesis of Retinal Endothelial Cells by Regulating Mitogen-Activated Protein Kinase Signaling Pathway. Current Topics in Nutraceutical Research, 20, 617-622. [Google Scholar] [CrossRef
[16] Liao, W., Huang, C., Wang, H., Lei, Y., Lin, H. and Huang, Y. (2023) Diosgenin, a Natural Steroidal Sapogenin, Alleviates the Progression of Diabetic Retinopathy in Diabetic Mice. In Vivo, 37, 661-666. [Google Scholar] [CrossRef] [PubMed]
[17] Cho, C., Roh, K., Lim, N., Park, S.J., Park, S. and Kim, H.W. (2022) Role of the JAK/STAT Pathway in a Streptozotocin-Induced Diabetic Retinopathy Mouse Model. Graefes Archive for Clinical and Experimental Ophthalmology, 260, 3553-3563. [Google Scholar] [CrossRef] [PubMed]
[18] Akhtar, S., Yousif, M.H.M., Dhaunsi, G.S., Sarkhouh, F., Chandrasekhar, B., Attur, S., et al. (2013) Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction. PLOS ONE, 8, e67813. [Google Scholar] [CrossRef] [PubMed]
[19] Hwang, S., Seong, H., Ryu, J., Jeong, J., Kang, T., Nam, K., et al. (2020) Phosphorylation of STAT3 and ERBB2 Mediates Hypoxia-Induced VEGF Release in ARPE-19 Cells. Molecular Medicine Reports, 22, 2733-2740. [Google Scholar] [CrossRef] [PubMed]
[20] Truong, T. and Silkiss, R.Z. (2023) The Role of Insulin-Like Growth Factor-1 and Its Receptor in the Eye: A Review and Implications for IGF-1R Inhibition. Ophthalmic Plastic & Reconstructive Surgery, 39, 4-12. [Google Scholar] [CrossRef] [PubMed]
[21] Lefevere, E., Van Hove, I., Sergeys, J., Steel, D.H.W., Schlingemann, R., Moons, L., et al. (2022) PDGF as an Important Initiator for Neurite Outgrowth Associated with Fibrovascular Membranes in Proliferative Diabetic Retinopathy. Current Eye Research, 47, 277-286. [Google Scholar] [CrossRef] [PubMed]
[22] Xian, Y., Wang, X., Yu, Y. and Chen, X. (2024) The Mechanism of EGFL7 Regulating Neovascularization in Diabetic Retinopathy through the PI3K/AKT/VEGFA Pathway. Life Sciences, 340, Article 122483. [Google Scholar] [CrossRef] [PubMed]
[23] Kowluru, R.A. and Kanwar, M. (2009) Translocation of H-Ras and Its Implications in the Development of Diabetic Retinopathy. Biochemical and Biophysical Research Communications, 387, 461-466. [Google Scholar] [CrossRef] [PubMed]
[24] Xie, H., Zhang, C., Liu, D., Yang, Q., Tang, L., Wang, T., et al. (2021) Erythropoietin Protects the Inner Blood-Retinal Barrier by Inhibiting Microglia Phagocytosis via Src/Akt/Cofilin Signalling in Experimental Diabetic Retinopathy. Diabetologia, 64, 211-225. [Google Scholar] [CrossRef] [PubMed]